Can Rigetti's Need for a Quantum Fab Reshape Its Long-Term Moat?

Rigetti said on its Q3 call that its 150mm Fremont fab will support development only through 2027 and is unlikely to deliver the >99.9% qubit fidelities needed for commercial systems, so management is pursuing partnerships with superconducting foundries, participation in U.S. government quantum manufacturing programs, or building a modern 200–300mm fab — actions that could materially improve process control, yields and economics and serve as a competitive differentiator if executed. Peer developments include Quantum Computing Inc. delivering its first commercial entangled-photon source and scaling production at its Tempe photonic foundry, and D-Wave moving its Advantage2 annealer (now >4,400 qubits) to full commercial availability via its Leap cloud and expanding hybrid quantum-classical offerings. Market context: RGTI is up 84.9% YTD, trades at a price-to-book of ~24.7, carries a Zacks Rank #3 (Hold) and faces analyst estimates that imply a large (~88.9%) decline in 2025 earnings, highlighting upside from technology milestones but significant near-term execution and profitability risk.

Analysis

Rigetti disclosed on its Q3 call that its 150mm Fremont fabrication line can support development only through 2027 but is unlikely to achieve the >99.9% qubit fidelities required for commercial-grade systems; management is pursuing three explicit paths—partnering with superconducting foundries, seeking participation in U.S. government quantum manufacturing initiatives, or building a modern 200–300mm fab with advanced tooling and automation. Management frames a future fab not as an open risk but as a potential competitive differentiator that would improve process control, qubit consistency, yields and long-term economics if executed successfully.

Market signals show a bifurcated picture: RGTI shares have risen 84.9% year-to-date yet trade at a price-to-book of ~24.7 and carry a Zacks Rank #3 (Hold), while the Zacks 2025 consensus implies an 88.9% decline in earnings versus the prior year, underscoring valuation and near-term profitability disconnects relative to technical milestones. Competitive context reinforces urgency—Quantum Computing Inc. has delivered a commercial entangled-photon source and is scaling its Tempe photonic foundry, and D-Wave has moved its Advantage2 annealer (>4,400 qubits) to full commercial availability via Leap across 40+ countries.

Key Decisions for Investors

• Monitor near-term announcements for a confirmed foundry partnership, government funding award, or a detailed 200–300mm fab capex and timeline, as any of these materially change dilution and execution risk
• Given RGTI's 84.9% YTD gain, elevated P/B (~24.7) and an 88.9% implied drop in 2025 earnings, consider trimming or refraining from adding to positions until the company provides concrete funding/execution clarity
• Evaluate selective exposure to peers QUBT and QBTS for nearer-term commercialization upside—QUBT's first commercial entangled-photon delivery and Tempe foundry scale, and QBTS's Advantage2 commercial availability and global Leap access are tangible revenue catalysts
• If maintaining a long-term stance on RGTI, use event-driven triggers (confirmed partnership or government program participation, published yield/fidelity metrics, or a detailed capex/dilution plan) before materially increasing exposure